P. Ghislain

发表

Ustekinumab improves nail disease in patients with moderate‐to‐severe psoriasis: results from PHOENIX 1

Y. Wasfi, Y. Poulin, S. Fakharzadeh, 2014, The British journal of dermatology.

Sustained long‐term efficacy and safety of adalimumab in paediatric patients with severe chronic plaque psoriasis from a randomized, double‐blind, phase III study

K. Papp, M. Seyger, K. Unnebrink, 2019, The British journal of dermatology.

International eDelphi Study to Reach Consensus on the Methotrexate Dosing Regimen in Patients With Psoriasis.

Vinod K. Sharma, M. Lebwohl, A. Oakley, 2022, JAMA dermatology.

Practical recommendations for systemic treatment in psoriasis according to age, pregnancy, metabolic syndrome, mental health, psoriasis subtype and treatment history (BETA‐PSO: Belgian Evidence‐based Treatment Advice in Psoriasis; part 1)

J. Lambert, A. Nikkels, S. Segaert, 2020, Journal of the European Academy of Dermatology and Venereology : JEADV.

Treatment patterns in moderate-to-severe plaque psoriasis: results from a Belgian cross-sectional study (DISCOVER)

J. Lambert, J. Lambert, P. Ghislain, 2017, The Journal of dermatological treatment.

Secukinumab Use in Patients with Moderate to Severe Psoriasis, Psoriatic Arthritis and Ankylosing Spondylitis in Real-World Setting in Europe: Baseline Data from SERENA Study

E. Lespessailles, P. Sfikakis, M. Augustin, 2020, Advances in Therapy.

Long‐term safety of ustekinumab in patients with moderate‐to‐severe psoriasis: final results from 5 years of follow‐up

B. Strober, M. Lebwohl, C. Griffiths, 2013, The British journal of dermatology.

Real-Life Effectiveness of Apremilast for the Treatment of Psoriasis in Belgium: Results From the Observational OTELO Study

Xuan Hoai, S. Segaert, M. de la Brassinne, 2022, Advances in Therapy.

Efficacy and safety of adalimumab every other week versus methotrexate once weekly in children and adolescents with severe chronic plaque psoriasis: a randomised, double-blind, phase 3 trial

K. Papp, K. Unnebrink, D. Thaçi, 2017, The Lancet.

A Belgian consensus on the definition of a treat‐to‐target outcome set in psoriasis management

S. Segaert, P. Ghislain, F. Willaert, 2019, Journal of the European Academy of Dermatology and Venereology : JEADV.

Efficacy and safety of baricitinib in combination with topical corticosteroids in patients with moderate‐to‐severe atopic dermatitis with inadequate response, intolerance or contraindication to ciclosporin: results from a randomized, placebo‐controlled, phase III clinical trial (BREEZE‐AD4) *

T. Bieber, K. Reich, M. Augustin, 2022, The British journal of dermatology.

[Orf in urban surroundings and religious practices: a study over a 3-year period].

P. Ghislain, Y. Dinet, J. Delescluse, 2001, Annales de dermatologie et de venereologie.

Practical recommendations for systemic treatment in psoriasis in case of coexisting inflammatory, neurologic, infectious or malignant disorders (BETA‐PSO: Belgian Evidence‐based Treatment Advice in Psoriasis; part 2)

J. Lambert, A. Nikkels, S. Segaert, 2020, Journal of the European Academy of Dermatology and Venereology : JEADV.

A phase IIIb, multicentre, randomized, double‐blind, vehicle‐controlled study of the efficacy and safety of adalimumab with and without calcipotriol/betamethasone topical treatment in patients with moderate to severe psoriasis: the BELIEVE study

J. Saurat, S. Chimenti, J. Ortonne, 2010, The British journal of dermatology.

Drug-induced eosinophilia and multisystemic failure with positive patch-test reaction to spironolactone: DRESS syndrome.

J. Lachapelle, D. Tennstedt, P. Ghislain, 2003, Acta dermato-venereologica.

An observational study of the real-life management of psoriasis patients treated with etanercept according to the new reimbursement criteria (in Belgium)

S. Segaert, P. Ghislain, C. Boone, 2016, The Journal of dermatological treatment.

Secukinumab demonstrated sustained retention, effectiveness and safety in a real‐world setting in patients with moderate‐to‐severe plaque psoriasis: long‐term results from an interim analysis of the SERENA study

T. Torres, D. Rigopoulos, M. Romanelli, 2022, Journal of the European Academy of Dermatology and Venereology : JEADV.

Recommendations for managing a suboptimal response to biologics for moderate-to-severe psoriasis: A Belgian perspective

S. Segaert, M. de la Brassinne, J. Lambert, 2016, The Journal of dermatological treatment.

Efficacy and systemic absorption of topical tacrolimus used in pyoderma gangrenosum

J. Lachapelle, I. De Decker, P. Ghislain, 2004, The British journal of dermatology.

[An unusual complication of bronchitis: Sweet's syndrome].

A. Beir, P. Ghislain, P. Modiano, 2000, Acta clinica Belgica.

Treatment of severe drug reactions: Stevens-Johnson syndrome, toxic epidermal necrolysis and hypersensitivity syndrome.

J. Roujeau, P. Ghislain, 2002, Dermatology online journal.

[Symmetrical benign lipomatosis of the tongue and Launois-Bensaude lipomatosis].

C. Creusy, P. Modiano, L. Legout, 1999, Annales de dermatologie et de venereologie.

Allopurinol is the most common cause of Stevens-Johnson syndrome and toxic epidermal necrolysis in Europe and Israel.

L. Naldi, C. Viboud, M. Mockenhaupt, 2008, Journal of the American Academy of Dermatology.

Spontaneous extrusion of hand grenade fragments from the face 60 years after injury.

P. Ghislain, 2003, JAMA.

Systemic treatment of children and adolescents with atopic dermatitis aged ≥2 years: a Delphi consensus project mapping expert opinion in Northern Europe

T. Agner, S. de Schepper, Å. Svensson, 2022, Journal of the European Academy of Dermatology and Venereology : JEADV.

Ixekizumab improves secondary lesional signs, pain and sexual health in patients with moderate‐to‐severe genital psoriasis

J. Dauendorffer, J. Merola, A. Brnabic, 2020, Journal of the European Academy of Dermatology and Venereology : JEADV.

SAT0287 Long-Term Safety Of Ustekinumab: 5 Years of Follow-Up from the Psoriasis Clinical Development Program Including Patients with Psoriatic Arthritis

B. Strober, M. Lebwohl, K. Papp, 2013 .

Real-Life Experience of Tralokinumab for the Treatment of Adult Patients with Severe Atopic Dermatitis: A Multicentric Prospective Study

P. Ghislain, M. Baeck, M. Jacobs, 2023, Clinical Drug Investigation.

Alopecia areata occurring during anti-TNF therapy: a national multicenter prospective study.

F. Aubin, M. Tauber, J. Berthelot, 2014, Journal of the American Academy of Dermatology.

Real‐life effectiveness and short‐term (16‐week) tolerance of guselkumab for psoriasis: a Belgian retrospective multicentre study

J. Lambert, V. del Marmol, F. Benhadou, 2020, Journal of the European Academy of Dermatology and Venereology : JEADV.

Effectiveness and short‐term (16‐week) tolerance of guselkumab for psoriasis under real‐life conditions: a retrospective multicenter study

J. Schmutz, É. Estève, Z. Reguiai, 2020, Journal of the European Academy of Dermatology and Venereology : JEADV.

Eosinophilic cellulitis of papulonodular presentation (Wells’ syndrome)

P. van Eeckhout, P. Ghislain, 2005, Journal of the European Academy of Dermatology and Venereology : JEADV.

Improvement in Hidradenitis Suppurativa and quality of life in patients treated with adalimumab: Real‐world results from the HARMONY Study

B. Kirby, P. Ghislain, A. Katoulis, 2021, Journal of the European Academy of Dermatology and Venereology : JEADV.

Fixed drug eruption due to fluconazole: a third case.

P. Ghislain, E. Ghislain, 2002, Journal of American Academy of Dermatology.

Orf contamination may occur during religious events.

P. Ghislain, Y. Dinet, J. Delescluse, 2000, Journal of American Academy of Dermatology.

Real-Life Effectiveness and Tolerance of Upadacitinib for Severe Atopic Dermatitis in Adolescents and Adults

P. Ghislain, L. de Montjoye, M. Baeck, 2023, Advances in therapy.

Clinical, Quality of Life, Patient Adherence, and Safety Outcomes of Short-Course (12 Weeks) Treatment with Cyclosporine in Patients with Severe Psoriasis (the Practice Study)

K. Denhaerynck, I. Abraham, C. Hermans, 2013, Annals of dermatology.

Lassueur-Graham Little-Piccardi Syndrome: A 20-Year Follow-Up

P. van Eeckhout, P. Ghislain, E. Ghislain, 2003, Dermatology.

Itchy papules of the axillae.

P. Ghislain, J. Delescluse, J. D. van Der Endt, 2002, Archives of dermatology.

Borrelia afzelii evidenced by polymerase chain reaction in a biopsy of nipple lymphocytoma

M. Delmée, J. Lachapelle, D. Tennstedt, 2003, The British journal of dermatology.

Effectiveness and tolerability of guselkumab in patients with psoriasis: A longitudinal Belgian retrospective multicenter study

H. Boonen, M. de la Brassinne, F. Benhadou, 2021, JAAD international.

Mycosis fungoides restricted to the palms: efficacy of methotrexate.

C. Creusy, P. Modiano, P. Ghislain, 2003, Acta dermato-venereologica.